Pre-Market Stocks News (April 27, 2007)

Print Email

(ABT) Abbott Labs received positive EU opinion for Humira in Crohn’s treatment.
(ARQL) ArQule and Kyowa Hakko Kogyo signed an exclusive license agreement in Asia for ARQ 197, c-met inhibitor in Japan.
(AT) Alltel $0.64 EPS vs $0.66e.
(BIDU) Baidu.com traded up 17% after beating estimates and guiding higher.
(BKC) Burger King $0.25 EPS vs $0.22e.
(BPO) Brookfield Properties $0.48 FFO vs $0
.48e.
(CAM) Cameron $0.88 EPS vs $0.81e.
(CMI) Cummins $1.42 EPS vs $0.93e; unsure if comparable.
(CRDN) Ceradyne $1.38 EPS vs $1.32e.
(EMKR) Emcore PhotoVoltaics gets NASA pact for solar panels on Mars unit.
(FLIR) Flir System,s $0.35 EPS vs $0.29e.
(ITT) ITT $0.76 EPS vs $0.70e.
(KLAC) KLA-Tencor trading down 2% after earnings.
(LZ) Lubrizol $$1.00 EPS vs $0.98e.
(MSFT) Microsoft trading up almost 5% after beating earnings.
(SCLN) SciClone Pharma announces Zadaxin and SCV-07 abstracts were accepted at ASCO.
(SPG) Simon Property Group $1.37 EPS vs $1.30e.
(WMI) Waste Management $0.42 EPS vs $0.36e.

JOn C. Ogg
April 27, 2007

RSS Facebook Twitter